I wonder why people assume it is FTO versus cardio protection as it was DTs hypothesis on cardio protection and formulation of clinical trials to prove as CSO. I think the answer is elsewhere on this one and probably comes down to other strategy either for shareholder value (which he seemed passionate about) or related to his role as CSO.
I wonder why people assume it is FTO versus cardio protection as...
-
- There are more pages in this discussion • 3,511 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.86 |
Change
-0.015(0.80%) |
Mkt cap ! $316.8M | |||
| Open | High | Low | Value | Volume |
| $1.88 | $1.88 | $1.79 | $163.0K | 89.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 34299 | $1.84 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.86 | 3635 | 1 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |